Despite conventional wisdom that the 23andMe business breakthrough is the direct-to-consumer model, it’s also the consolidation of genetic testing, diagnosis and drug development that has the potential to change the industry.
Five things for pharma marketers to know: Wednesday, October 21, 2015
Pregnant women taking Prozac or Paxil have higher risks of birth defects; study finds J&J’s experimental psoriasis drug works better than Humira; AstraZeneca divests global rights to Entocort